Yahoo Finance • 7 months ago

ARK Invest's Cathie Wood Snags These 3 Bargains — Are They Right for Your Portfolio?

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Cathie Wood, co-founder, CEO, and investment manager of the ARK Invest family of exchange-traded funds, regularly discloses her stock tra... Full story

Yahoo Finance • 7 months ago

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Cathie Wood makes it easy to keep tabs on her aggressive growth stock habits. The co-founder, CEO, and investment manager of the Ark Invest family of exchange-traded funds publishes her transactions at the end of every trading day. She bec... Full story

Yahoo Finance • 10 months ago

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2023 Earnings Call Transcript

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2023 Earnings Call Transcript February 14, 2024 Adaptive Biotechnologies Corporation beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.32. Adaptive Biotechnolog... Full story

Yahoo Finance • last year

16 Best Penny Stocks To Buy For 2024

In this article, we will take a detailed look at the16 Best Penny Stocks To Buy For 2024. For a quick overview of such stocks, read our article 5 Best Penny Stocks To Buy For 2024. The stock market’s optimism wave recently saw a break aft... Full story

Yahoo Finance • last year

Adaptive Biotechnologies Reports Third Quarter 2023 Financial Results and Provides Business Update

SEATTLE, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into... Full story

Yahoo Finance • last year

Adaptive Biotechnologies Announces New Translational Collaboration to Measure Minimal Residual Disease with clonoSEQ® Assay Across BeiGene’s Lymphoid Malignancy Pipeline

Data generated by Adaptive’s next-generation sequencing-based MRD assay will support the development and commercialization of investigational medicines for hematologic malignancies SEATTLE, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Adaptive Bio... Full story

Yahoo Finance • last year

Adaptive Biotechnologies to Report Third Quarter Financial Results on November 9, 2023

SEATTLE, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose... Full story

Yahoo Finance • last year

Adaptive Announces Launch of Epic Integration for clonoSEQ®

SEATTLE, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnos... Full story

Yahoo Finance • last year

Adaptive Biotechnologies to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

SEATTLE, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into... Full story

Yahoo Finance • last year

Adaptive Biotechnologies to Report Second Quarter Financial Results on August 2, 2023

SEATTLE, July 10, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into... Full story

Yahoo Finance • 2 years ago

11 Best Medical  Stocks Under $10

In this piece, we will take a look at the eleven best medical stocks under $10. If you want to skip our analysis of the medical industry and recent trends, head on over to 5 Best Medical  Stocks Under $10. The medical industry is one of t... Full story

Yahoo Finance • 2 years ago

Why Shares of Adaptive Biotechnologies Jumped This Week

Shares of Adaptive Biotechnologies (NASDAQ: ADPT) were up 15.7% for the week after climbing as high as 20.5%, according to data provided by S&P Global Market Intelligence. Adaptive said the Food and Drug Administration (FDA) had accepted t... Full story

Yahoo Finance • 2 years ago

Adaptive Biotechnologies to Participate in the 2023 RBC Capital Markets Global Healthcare Conference

SEATTLE, May 12, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into c... Full story

Yahoo Finance • 2 years ago

Adaptive Biotechnologies Announces FDA Acceptance of Genentech’s Investigational New Drug Application for the First Neoantigen-Directed T-Cell Therapy Product in Oncology

SEATTLE, May 09, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to detect an... Full story

Yahoo Finance • 2 years ago

Adaptive Biotechnologies Announces Translational Collaboration with Takeda to Measure Minimal Residual Disease with Its clonoSEQ® Assay Across Its Hematologic Malignancy Pipeline

SEATTLE, April 12, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnos... Full story

Yahoo Finance • 2 years ago

Adaptive Biotechnologies to Report First Quarter Financial Results on May 3, 2023

SEATTLE, April 06, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into... Full story

Yahoo Finance • 2 years ago

Adaptive Biotechnologies to Participate in the 43rd Annual Cowen Healthcare Conference

SEATTLE, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into... Full story

Yahoo Finance • 2 years ago

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results

SEATTLE, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into... Full story

Yahoo Finance • 2 years ago

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 14, 2023

SEATTLE, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into... Full story

Yahoo Finance • 2 years ago

Capella Space Raises $60M in Growth Equity from the United States Innovative Technology Fund to Expand Satellite Imaging Capacity and Meet Rapidly Growing Customer Demand

Leading provider of Earth observation data, utilizing Synthetic Aperture Radar (SAR), announces revenue tripled; brings on new CFO/COO, CISO and CHRO for next phase of growth SAN FRANCISCO, Jan. 10, 2023 /PRNewswire/ -- Capella Space, a l... Full story